Cargando…
Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
Autores principales: | McQueenie, Ross, Foster, Hamish M. E., Jani, Bhautesh D., Katikireddi, Srinivasa Vittal, Sattar, Naveed, Pell, Jill P, Ho, Frederick K., Niedzwiedz, Claire L., Hastie, Claire E., Anderson, Jana, Mark, Patrick B., Sullivan, Michael, O’Donnell, Catherine A., Mair, Frances S., Nicholl, Barbara I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101730/ https://www.ncbi.nlm.nih.gov/pubmed/33956868 http://dx.doi.org/10.1371/journal.pone.0251613 |
Ejemplares similares
-
Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020) -
Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study
por: Hanlon, Peter, et al.
Publicado: (2018) -
Chronic pain and COVID-19 hospitalisation and mortality: a UK Biobank cohort study
por: Hastie, Claire E., et al.
Publicado: (2023) -
The association between a lifestyle score, socioeconomic status, and COVID-19 outcomes within the UK Biobank cohort
por: Foster, Hamish M. E., et al.
Publicado: (2022) -
Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
por: Niedzwiedz, Claire L., et al.
Publicado: (2020)